Menu

Selfish Yeast Genes Encode Both Toxin and Antidote

By spreading a poison and hoarding the remedy, wtf4 improves its chances of being inherited. 

Jun 20, 2017
Diana Kwon

Wtf4 antidote (pink) is gamete-specific and wtf4 poison (blue) acts on all sex cellsMMARÍA ANGÉLICA BRAVO NÚÑEZ AND NICOLE NUCKOLLS.

Scientists have discovered that wtf4, a gene from the yeast Schizosaccharomyces kambucha, boosts its odds of being passed down by encoding both a poison and an antidote, according to a study published today (June 20) in eLife.

In a 2014 study, Sarah Zanders, a geneticist at the Stowers Institute for Medical Research in Kansas City, and colleagues discovered that in two yeast species, S. pombe and S. kambucha, meiotic drivers—genes that boost their chances of survival by interfering with meiosis—could cause infertility.

Now, the team has uncovered one of the genes that are responsible for this effect—wtf4. This gene disrupts meiosis by generating two transcripts: one short RNA that encodes a toxic protein and one long RNA that encodes an antitoxin protein. The poison is released into the environment, killing gametes, but the antidote stays in the sex cells that retain wtf4 in their genomes, protecting them from destruction. Such toxin-antitoxin systems also exist in bacterial and archaeal cells.

See “A Movable Defense

“The wtf genes make a poison that has the potential to kill everything, including themselves. That’s risky. Having this second component that’s an antidote, and keeping the antidote private, is the way they figured out how to selectively eliminate their competition,” Zanders says in a statement. “Meiotic drive systems like wtf genes could potentially be used to eradicate pest populations or to facilitate the spread of desirable traits in natural populations.” 

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!